Save the Date
November 18 – 19, 2020 • Harvard Medical School, Boston, MA
The 16th Annual Personalized Medicine Conference is being organized by a cross-industry, cross-disciplinary panel, made up of providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of personalized medicine.
EDWARD ABRAHAMS, PH.D.
President, Personalized Medicine Coalition
Bonnie J. Addario
Co-Founder, Chair, GO2 Foundation for Lung Cancer; lung cancer survivor
Director, Alliance Development, Biotechnology Innovation Organization
Alex J. Carlisle, Ph.D.
Chairman, CEO, National Alliance Against Disparities in Patient Health
Vice President, Global Advocacy Relations, Amgen
William S. Dalton, Ph.D., M.D.
Founder, Executive Chairman, M2Gen
International Product Manager, Genentech
Stephen L. Eck, M.D., Ph.D.
Chief Medical Officer, Immatics US
Richard Hamermesh, D.B.A.
Co-Faculty Chair, Harvard Business School Kraft Precision Medicine Accelerator
Kris Joshi, Ph.D.
Executive Vice President, President, Network Solutions, Change Healthcare
President, National Pharmaceutical Council
Anne-Marie Martin, Ph.D.
Senior Vice President, Global Head of Precision Medicine, Novartis
Founder, Publisher, Genome magazine
Howard McLeod, Pharm.D.
Medical Director, DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center
Founder, Managing Partner, GreyBird Ventures LLC
Cynthia Casson Morton, Ph.D.
William Lambert Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School
Lincoln Nadauld, M.D., Ph.D.
Executive Director, Precision Medicine and Precision Genomics, Intermountain Healthcare
Michael J. Pellini, M.D.
Managing Partner, Section 32
Chairman of the Board, CEO, President, Genomic Health
Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Worldwide Research & Development, Pfizer
Michael Sherman, M.D.
Chief Medical Officer, Senior Vice President, Harvard Pilgrim Health Care
Ralph Snyderman, M.D.
James B. Duke Professor of Medicine, Duke University
Chief Communications Officer, SomaLogic
Mark P. Stevenson
Executive Vice President, Chief Operating Officer, Thermo Fisher Scientific
Alex Vadas, Ph.D.
Managing Director, Partner, LEK Consulting
Global Head, Janssen Diagnostics, Johnson & Johnson
Jay G. Wohlgemuth, M.D.
Chief Medical Officer, Senior Vice President, Quest Diagnostics